Suppression of inflammatory cytokine production and oxidative stress by CO-releasing moleculesliberated CO in the small intestine of thermally-injured mice

Acta Pharmacologica Sinica

Volumn 29, Issue 7, 2008, Pages 838-846

  Liu, Dong Ming ^a   Sun, Bing Wei ^a   Sun, Zhi Wei ^a   Jin, Qin ^a   Sun, Yan ^a   Chen, Xi ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Carbon monoxide; Cytokine; Oxidative stress; Small intestine; Thermal injury

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; CARBON MONOXIDE RELEASING MOLECULE 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BURN; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT INJURY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SMALL INTESTINE; TISSUE HOMOGENATE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BURNS; CACO-2 CELLS; CARBON MONOXIDE; CELLS, CULTURED; CYTOKINES; HUMANS; INTESTINE, SMALL; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 65849212462     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00816.x     Document Type: Article

References (48)

1. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998; 10: 79-89.
2. Harris BH, Gelfand JA. The immune response to trauma. Semin Pediatr Surg 1995; 4: 77-82.
3. Saffle JR, Sullivan JJ, Tuohig GM, Larson CM. Multiple organ failure in patients with thermal injury. Crit Care Med 1993; 21: 1673-83.
4. Dehne MG, Sablotzki A, Hoffmann A, Muhling J, Dietrich FE, Hempelmann G. Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 2002; 28:535-42.
5. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
6. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26: S64-74.
7. Moore EE. Mesenteric lymph: the critical bridge between dysfunctional gut and multiple organ failure. Shock 1998; 10: 415- 6.
8. Ward PA, Till GO. Pathophysiologic events related to thermal injury of skin. J Trauma 1990; 30: S75-9.
9. Li L, Zhang YM, Qiao WL, Wang L, Zhang JF. Effects of hypothalamic paraventricular nuclei on apoptosis and proliferation of gastric mucosal cells induced by ischemia/reperfusion in rats. World J Gastroenterol 2007; 13: 874-81.
10. Liu KX, Wu WK, He W, Liu CL. Ginkgo biloba extract (EGb 761) at tenuates lung injury induced by intestinal ischemia/ reperfusion in rats: Roles of oxidative stress and nitric oxide. World J Gastroenterol 2007; 13: 299-305.
11. Sener G, Sehirli AO, Satýrog H, Keyer-Uysal M, C Yeǒen B. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns 2002; 28: 419-25.
12. Horton JW. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 2003; 189: 75-88.
13. Sun Z, Wang X, Lasson AE, Böjesson A, Annborn M, Andersson R. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol 2001; 36: 55-65.
14. Ghandour S, Cetinel S, Kurtel H. Endothelin-3 induced mesenteric vasoconstr iction and PMN infil trat ion in the rat small intestine: role of endothelin receptors. Regulatory Peptides 2004; 119:125-31.
15. Karabeyoglu M, Unal B, Bozkurt B, Dolapçi I, Bi lgihan A, Karabeyoglu I, et al. The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J Surg Res 2008; 144: 59-63.
16. Ko JS, Yang HR, Chang JY, Seo JK. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-?. World J Gastroenterol 2007; 13: 1962-5.
17. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress. Role of bilirubin generatedby the enzyme. Circ Res 1999; 85: 663-71.
18. Lee T, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8: 240- 6.
19. Otterbein LE, Soares M, Yamashita K, Bach FH. Heme oxygenase- 1: unleashing the protective properties of heme. Trends Immunol 2003; 24: 449-55.
20. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxide- releasing molecules. Curr Pharm Des 2003; 9: 2525-39.
21. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90: E17-24.
22. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, et al. CORM-A1: a new pharmacologically active carbon monoxide- releasing molecule. FASEB J 2005; 19: 284-6.
23. Johnson TR, Mann BE, Clark JE, Foresti R, Green CJ, Motterlini R. Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl 2003; 42: 3722-9.
24. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, et al. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 2004;142: 453-60.
25. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93: 2-8.
26. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, et al. Administration of a coreleasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286: H1649-53
27. Sun BW, Chen ZY, Chen X, Liu C. Attenuation of leukocytes sequestration by carbon monoxide-releasing molecules: liberated carbon monoxide in the liver of thermally injured mice. J Burn Care Res 2007; 28: 173-81.
28. Sun B, Sun H, Liu C, Shen J, Chen Z, Chen X. Role of COreleasing molecules (CORM-2)-liberated CO in attenuating leukocytes sequestration and inflammatory responses in the lung of thermally injured mice. J Surg Res 2007; 139: 128-35.
29. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, et al. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005; 38: 127-34.
30. Faunce DE, Gregory MS, Kovacs EJ. Effects of acute ethanol exposure on cel lular immune responses in a murine model of thermal injury. J Leukoc Biol 1997; 62: 733-40.
31. Gamelli RL, He LK, Liu H. Macrophage suppression of granulocyte and macrophage growth following burn wound infection. J Trauma 1994; 37: 888-92.
32. Stengle J, Meyers R, Pyle J, Dries DJ. Neutrophil recruitment after remote scald injury. J Burn Care Rehab 1996; 17: 14-8.
33. Faunce DE, Llanas JN, Patel PJ, Gregory MS, Duffner LA, Kovacs EJ. Neutrophil chemokine production in the skin following scald injury. Burns 1999; 25: 403-7.
34. Rana SN, Li X, Chaudry IH, Bland KI, Choudhry MA. Inhibition of IL-18 reduces myeloperoxidase activity and prevents edema in intestine following alcohol and burn injury. J Leukoc Biol 2005; 77: 719-28.
35. Cepinskas G, Lush CW, Kvietys PR. Anoxia/reoxygenationinduced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothel ial cel ls: a nuclear factor-?B phenomenon, Circ Res 1999; 84: 103-12
36. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
37. Sun BW, Jin Q, Sun Y, Sun ZW, Chen X, Chen ZY, et al. CO liberated from CO-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice. World J Gastroenterol 2007; 13: 6183-90.
38. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001; 250: 91-104.
39. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001; 160: 457-63.
40. Lin F, Spencer D, Hatala DA, Levine AD, Medof ME. Decayaccelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol 2004; 172: 3836-41.
41. Van Assche G, Rutgeerts P. Anti-TNF agents in Crohn's disease. Expert Opin Investig Drugs 2000; 9: 103-11.
42. Kollias G, Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti- TNF treatments. Cytokine Growth Factor Rev 2002; 13: 315- 21.
43. Hirata I, Yasumoto S, Toshina K, Inoue T, Nishikawa T, Murano N, et al. Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate- induced colitis. World J Gastroenterol 2007; 13: 1666-71.
44. Kabaroglu C, Akisu M, Habif S, Mutaf I, Turgan N, Parildar Z, et al. Effects of L-arginine and L-carnitine in hypoxia/reoxygenationinduced intestinal injury. Pediatr Int 2005; 47: 10-14.
45. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Therap 1988; 37: 231-49.
46. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50.
47. Van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1: 1491-500.
48. Miki S, Takeyama N, Tanaka T. Immune dysfu nct ion in endotoxicosis: Role of nitric oxide produced by inducible nitric oxide synthase. Crit Care Med 2005; 33: 716-20.